Withdrawal
“Comparative Efficacy of Sirolimus‐Eluting Stents and Paclitaxel‐Eluting Stents in East Asian Versus non‐East Asian Patients: A Systematic Review& Meta ‐Analysis” by Zhao, R., Lu, Q., Yang, R., Du, J., Deng, S. and She, Q.1The above article from theCardiovascular Therapeutics, published online on 05 January 2017 in Wiley Online Library (http://wileyonlinelibrary.com) has been withdrawn.REFERENCE1. Zhao, R., Lu, Q., Yang, R., Du, J., Deng, S. and She, Q. (2017), Comparative Efficacy of Sirolimus ‐Eluting Stents and Paclitaxel‐Eluting Stents in East Asian Versus non‐East Asian Patients: A Systematic Review&...
Source: Cardiovascular Therapeutics - March 9, 2021 Category: Cardiology Tags: WITHDRAWAL Source Type: research
Withdrawal
‘MicroRNA‐27a mediates the Wnt/β‐catenin pathway to affect the myocardial fibrosis in rats with chronic heart failure’ by Zhuang, Y., Liao, Y., Liu, B., Fang, Z., Chen, L., Min, L. and Chen, W.1The above article from theCardiovascular Therapeutics, published online on 20 September 2018 in Wiley Online Library (http://wileyonlinelibrary.com) has been withdrawn.REFERENCE1. Zhuang, Y., Liao, Y., Liu, B., Fang, Z., Chen, L., Min, L. and Chen, W. (2019), MicroRNA ‐27a mediates the Wnt/β‐catenin pathway to affect the myocardial fibrosis in rats with chronic heart failure. Cardiovasc Ther. Accepted Author Manuscript...
Source: Cardiovascular Therapeutics - March 22, 2019 Category: Cardiology Tags: WITHDRAWAL Source Type: research
Withdrawal
“Comparative Efficacy of Sirolimus‐Eluting Stents and Paclitaxel‐Eluting Stents in East Asian Versus non‐East Asian Patients: A Systematic Review& Meta ‐Analysis” by Zhao, R., Lu, Q., Yang, R., Du, J., Deng, S. and She, Q.1The above article from theCardiovascular Therapeutics, published online on 05 January 2017 in Wiley Online Library (http://wileyonlinelibrary.com) has been withdrawn.REFERENCE1. Zhao, R., Lu, Q., Yang, R., Du, J., Deng, S. and She, Q. (2017), Comparative Efficacy of Sirolimus ‐Eluting Stents and Paclitaxel‐Eluting Stents in East Asian Versus non‐East Asian Patients: A Systematic Review&...
Source: Cardiovascular Therapeutics - March 21, 2019 Category: Cardiology Tags: WITHDRAWAL Source Type: research
Use of acetazolamide in the treatment of patients with refractory congestive heart failure
ConclusionIn a cohort of patients with refractory CHF treated with an intensive diuretic treatment, the addition of acetazolamide was associated with improvement in functional class and surrogates of fluid overload. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - January 28, 2019 Category: Cardiology Authors: Julio N úñez,
Raquel Heredia,
Ana Payá,
Ignacio Sanchis,
Susana Prado,
Gema Miñana,
Enrique Santas,
Rafael Espriella,
Eduardo Núñez,
Juan Sanchis,
Antoni Bayés‐Genís Tags: SHORT COMMUNICATION Source Type: research
Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan
SummaryElevated blood pressure (BP) is a major determinant of morbidity and mortality burden related to cardio ‐metabolic risk. Current guidelines indicate that controlling and lowering BP promotes cardiovascular (CV) risk reduction. Among antihypertensive agents, angiotensin receptor blockers (ARBs) are characterized by an efficacy profile equivalent to other antihypertensive agents and are provided with excellent tolerability and low discontinuation rates during chronic treatments. Moreover, CV outcomes are reduced by ARBs. Olmesartan is a long‐lasting ARB which proved to achieve a comparable or more effective action...
Source: Cardiovascular Therapeutics - January 28, 2019 Category: Cardiology Authors: Stefano Omboni,
Massimo Volpe Tags: UNSOLICITED REVIEW Source Type: research
Issue Information
(Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - January 28, 2019 Category: Cardiology Tags: ISSUE INFORMATION Source Type: research
Evidence ‐based pharmacotherapies used in the postdischarge phase are associated with improved one‐year survival in senior patients hospitalized with heart failure
ConclusionsIn a cohort of senior patients hospitalized with HF, dispensing of a RASI or β‐blocker within 60 days postdischarge is associated with a 1‐year survival benefit. Early postdischarge support programs after recent HF hospitalization should include measures to optimize adherence to evidence‐based medications. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - January 28, 2019 Category: Cardiology Authors: Xiwen Qin,
Joseph Hung,
Matthew Knuiman,
Tiew ‐Hwa K. Teng,
Tom Briffa,
Frank M. Sanfilippo Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Role of interleukin ‐7 in fusion of rat bone marrow mesenchymal stem cells with cardiomyocytes in vitro and improvement of cardiac function in vivo
ConclusionInterleukin ‐7 is able to enhance the fusogenic properties of MSCs and improve cardiac function. This improvement may be attributed to the supportive action of IL‐7 on cell proliferation and cell survival contributing to the regeneration of damaged myocardium. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - January 28, 2019 Category: Cardiology Authors: Kanwal Haneef,
Anwar Ali,
Irfan Khan,
Nadia Naeem,
Siddiqua Jamall,
Asmat Salim Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Activation of AMPK alleviates cardiopulmonary bypass ‐induced cardiac injury via ameliorating acute cardiac glucose metabolic disorder
In conclusion, it was suggested in this study that preactivation of AMPK by AICAR improved myocardial glucose uptake by promoting AS160 dependent myocardial membrane GLUT‐4 translocation, which ultimately provided a potent cardioprotective effect. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - January 28, 2019 Category: Cardiology Authors: Zhifa Wang,
Yukun Cao,
Qiang Yin,
Yuehu Han,
Yunya Wang,
Guocheng Sun,
Hailong Zhu,
Ming Xu,
Chunhu Gu Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Statins and risk of cataracts: A systematic review and meta ‐analysis of observational studies
ConclusionsThe results point out an increased risk of cataract development with statins. However, since the magnitude of the effect is low and between ‐studies heterogeneity is high, the extent in which these results have impact on the benefit/risk ratio of statins is difficult to ascertain due to the uncertainty of the findings. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - January 28, 2019 Category: Cardiology Authors: Carlos Alves,
Diogo Mendes,
Francisco Batel Marques Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Clinical effectiveness and safety of antazoline ‐based therapy in patients with stable coronary artery disease undergoing pharmacological cardioversion of short‐duration atrial fibrillation in the emergency department
ConclusionsIn selected patients with a stable CAD, even with a history of MI, antazoline ‐based CV of short‐duration AF may be an effective and safe therapeutic option. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - January 28, 2019 Category: Cardiology Authors: Michal M. Farkowski,
Aleksander Maciag,
Malgorzata Zurawska,
Ilona Kowalik,
Hanna Szwed,
Mariusz Pytkowski Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Beneficial effects of tolvaptan on atrial remodeling induced by chronic intermittent hypoxia in rats
ConclusionsCIH ‐induced significant atrial remodeling in our rat model, which was attenuated by tolvaptan. These changes may be explained due to alterations in miR‐21/Spry1/ERK/MMP‐9, miR‐21/PTEN/PI3K/AKT, and NF‐κB pathways by tolvaptan. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - January 28, 2019 Category: Cardiology Authors: Kai Zhang,
Zuowang Ma,
Weiding Wang,
Ruimeng Liu,
Yue Zhang,
Meng Yuan,
Guangping Li Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Effect of evidence ‐based cardiac drug therapy on mortality in patients with acute coronary syndrome: Findings from the Gulf COAST registry
ConclusionsAmong patients discharged after an ACS event, concurrent EBM prescribing was associated with lower all ‐cause mortality that persists for up to 12‐months posthospital discharge. The relative benefits of EBMs were also consistent across age, GRACE risk score, and discharge diagnosis. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - January 28, 2019 Category: Cardiology Authors: Ibrahim Al ‐Zakwani,
Mohammad Zubaid,
Alawi A. Alsheikh‐Ali,
Wael Almahmeed,
Wafa Rashed Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Effect of multidisciplinary cardiac rehabilitation on the response to cardiac resynchronization therapy
ConclusionsFollowing CRT ‐implant, the participation in a structured CR‐program is safe and beneficially influences symptomatic response and clinical outcome. The beneficial effects of exercise training are potentially independent and additive to the beneficial reverse remodeling effect induced by CRT itself. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - January 28, 2019 Category: Cardiology Authors: Pieter Martens,
Guy Jacobs,
Matthias Dupont,
Wilfried Mullens Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
